Tribune Review – *Also published in the Butler Eagle
In Tribune Review, Jeff S. warns that copying international pricing schemes stalls the rollout of breakthrough cures and restricts therapeutic selections, especially for overextended households and patients across Pennsylvania. Alternatively, Jeff S. urges federal lawmakers to prioritize localized market corrections, such as dismantling vertical corporate monopolies and injecting transparency into medication transactions, to deliver financial relief without undermining medical quality.